NCT01575574View on ClinicalTrials.gov

Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Hepatocellular Carcinoma

Interventions

DRUG

GADOXETIC ACID

all patients will have a magnetic resonance with gadobutrol as reference for diagnosis; in participants an additional magnetic resonance will be done with the new contrast agent to verify if the diagnostic can be done.

Trial Locations (1)

08036

Hospital Clinic of Barcelona, Barcelona

All Listed Sponsors

lead

Sara Varea

OTHER

NCT01575574 - Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis | Biotech Hunter | Biotech Hunter